Please assess the completion status of the following clinical trial:

Trial Title: Femoral Peri-arterial Local Anesthetic Injection Decreases Tourniquet Associated Ischemic Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients that will be included in the study are English speaking 18-75 year old ASA 1-3 patients undergoing total ankle arthroplasty.~Exclusion Criteria:~1. ASA 4 or 5~2. Diagnosis of chronic pain~3. Daily chronic opioid use (over 3 months of continuous opioid use).~4. Inability to communicate pain scores or need for analgesia.~5. Infection at the site of block placement~6. Age under 18 years old or greater than 75 years old~7. Pregnant women (as determined by standard of care day-of surgery urine bHCG)~8. Intolerance/allergy to local anesthetics~9. Weight \<50 kg~10. Suspected, or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past 2 years.~11. Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the opinion of the investigator, may interfere with study assessments or compliance.~12. Current or historical evidence of any clinically significant disease or condition that, in the opinion of the investigator, may increase the risk of surgery or complicate the subject's postoperative course

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Mepivacaine Block Group (Type: EXPERIMENTAL): Injection of local anesthetic (mepivacaine) above and beside the femoral artery.
- Saline Sham Group (Type: PLACEBO_COMPARATOR): Injection of salt water (saline) above and beside the femoral artery.

Based on this trial design, predict the completion outcome and termination type (if applicable).